Prolynx LLC
🇺🇸United States
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase I Study of PLX038 in Patients With Advanced Solid Tumors
- First Posted Date
- 2016-01-06
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- ProLynx LLC
- Target Recruit Count
- 40
- Registration Number
- NCT02646852
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
News
No news found